Archief

TRAP

Feasibility study of chemoradiation. TRAstuzumab and Pertuzumab in resectable HER2+ esophageal carcinoma: the TRAP study EudraCT nummer: 2013-004111-42 METc nummer: 2014.257 Onderzoekscode:   Samenvatting Bij resectabele oesophaguscarcinomen en…

TULIP

A multi-centre, open-label, randomized clinical trial comparing the efficacy and safety of the antibody-drug conjugate SYD985 to physician’s choice in patients with HER2-positive unresectable locally advanced or metastatic…

Vascular fingerprint

Vascular fingerprint to identify patients at risk for arterial cardiovascular events within the first year after start of cisplatin-based chemotherapy for testicular cancer: a validation study. METc nummer:…

ZEJULA/Pass studie Niraparib

Post-authorization safety study to evaluate the risks of myelodysplastic syndrome/acute myeloid leukemia and second primary malignancies in adult patients with platinum-sensitive, relapsed, high-grade serous epithelial ovarian, fallopian tube,…

ZEPHIR

A phase II prospective imaging study evaluating the utility of pre-treatment zirconium-89 labelled trastuzumab PET/CT and an early FDG-PET/CT response to identify patients with advanced HER-2 positive breast…